◄ back to all posts

NVS: Novartis AG Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 211,945.20
Enterprise Value ($M) n/a
Book Value ($M) n/a
Book Value / Share n/a
Price / Book n/a
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets n/a
Assets n/a
Liabilities n/a
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income n/a
Net Income n/a

Cash Flow Statement (mra) ($M)
Cash From Operations n/a
Cash from Investing n/a
Cash from Financing n/a

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-02-26 300,104 2,230,100 13.46
2021-02-25 381,162 2,110,133 18.06
2021-02-24 214,113 2,571,200 8.33
2021-02-23 216,968 2,119,200 10.24

(click for more detail)

(click for list of largest short owners)

Similar Companies
MRK – Merck & Co., Inc. NUVB – Nuvation Bio Inc.
NVO – Novo-Nordisk A/S PBH – Prestige Brands Holdings, Inc.
PFE – Pfizer, Inc.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts

Holistic